Oxygenta Pharmaceutical Limited (BOM:524636)
India · Delayed Price · Currency is INR 108.45
-4.50 (-3.98%)
At close: Jul 14, 2025
Oxygenta Pharmaceutical Revenue
In the fiscal year ending March 31, 2025, Oxygenta Pharmaceutical had annual revenue of 1.09B INR with 175.71% growth. Oxygenta Pharmaceutical had revenue of 494.67M in the quarter ending March 31, 2025, with 368.77% growth.
Revenue
1.09B
Revenue Growth
+175.71%
P/S Ratio
3.57
Revenue / Employee
6.79M
Employees
161
Market Cap
3.91B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.09B | 696.57M | 175.71% |
| Mar 31, 2024 | 396.42M | 86.55M | 27.93% |
| Mar 31, 2023 | 309.88M | -295.37M | -48.80% |
| Mar 31, 2022 | 605.25M | 84.98M | 16.33% |
| Mar 31, 2021 | 520.27M | 383.01M | 279.03% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,882.72B |
| HDFC Bank | 2,728.47B |
| Tata Consultancy Services | 2,561.48B |
| Bharti Airtel | 1,729.85B |
| ICICI Bank | 2,006.54B |
| State Bank of India | 3,429.39B |
| Infosys | 1,647.16B |
| Hindustan Unilever | 631.21B |